证券代码：600828 证券简称：茂业商业 编号：临 2025-026 号 茂业商业股份有限公司 关于签署商业项目托管服务合同暨关联交易的公告 特别提示：本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带责任。 重要内容提示： 一、关联交易概述 大中华国际集团（中国）有限公司（以下简称"大中华集团"） 拟与茂业商业股份有限公司（以下简称"茂业商业"、"公司"）全 资子公司深圳茂业百货有限公司（以下简称"茂业百货"）控股的深 圳茂业商业管理有限公司（以下简称"茂业商管"）签署《商业项目 托管服务合同》，将大中华集团旗下的大中华国际金融中心商业项目、 大中华环球经贸中心项目、大中华国际交易广场项目（以下简称"合 作商业项目"）委托茂业商管进行开业筹备、招商、运营管理服务。 本次交易系茂业商管利用自身在商业运营、管理方面的品牌与资 源优势及丰富的管理和服务经验，为交易对方提供商业项目托管服务， 有利于提升公司业绩，增加公司营业利润。本次交易不会对公司的独 立运营、财务状况和经营结果形成不利影响。 公司于2025年6月17日以现场结合通 ...

证券代码：002772 证券简称：众兴菌业 公告编号：2025-035 天水众兴菌业科技股份有限公司 二、监事会会议审议情况 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 经与会监事认真审议，本次会议以记名投票表决方式表决通过了《关于与关 联方共同投资暨关联交易的议案》。 监事会认为：本次关联交易有利于进一步激发管理人员和技术骨干的积极 性，有利于提升公司综合竞争力，符合公司发展战略；本次交易价格客观公正、 平等自愿、价格公允合理；同时本次交易事项审议及决策程序合法合规，不存在 损害公司及全体股东利益的情形；综上所述，监事会同意本次交易事项。 表决情况：3 票同意、0 票反对、0 票弃权、0 票回避 表决结果：通过 本议案尚需提交公司股东大会审议，关联股东回避表决。 一、监事会会议召开情况 天水众兴菌业科技股份有限公司（以下简称"公司"）第五届监事会第八次 会议于 2025 年 06 月 20 日在公司会议室以通讯方式召开。召开本次会议的通知 已于 2025 年 06 月 16 日以电子邮件方式送达各位监事。 本次会议由监事会主席张天荣先生主持，会议应出席监 ...

北京元六鸿远电子科技股份有限公司 关联交易管理办法 第一章 总 则 第一条 为规范北京元六鸿远电子科技股份有限公司（以下简称"公司"）关 联交易行为，提高公司规范运作水平，保护投资者合法权益，根据《上海证券交 易所股票上市规则》《上海证券交易所上市公司自律监管指引第 5 号——交易与 关联交易》等法律、法规、规范性文件及《北京元六鸿远电子科技股份有限公司 章程》（以下简称"《公司章程》"）的有关规定，结合公司实际情况，制定本 办法。 第五条 公司的关联人包括关联法人（或者其他组织）和关联自然人。 第六条 具有以下情形之一的法人（或者其他组织），为公司的关联法人（或 者其他组织）： （一）直接或者间接控制公司的法人（或者其他组织）； （二）由前项所述法人（或者其他组织）直接或者间接控制的除公司、控股 子公司及控制的其他主体以外的法人（或者其他组织）； 第二条 本办法适用于公司及纳入公司合并会计报表范围的子公司。公司及 纳入公司合并会计报表范围的子公司相关责任人应对关联交易进行管理。如果拟 发生的交易构成关联交易，应当及时向董事会办公室报告，在公司履行相关审议、 披露程序后方可进行交易。 第三条 公司关联交易应当 ...

（2011 年 3 月 25 日经 2011 年度第二次临时股东大会批 准，2018 年 11 月 20 日经 2018 年度第一次临时股东大会第 一次修订，2021 年 11 月 18 日经 2021 年第一次临时股东大 会第二次修订，2025 年 6 月 16 日经 2024 年度股东会第三次 修订） 第一章 总则 第一条 为规范中国交通建设股份有限公司（简称公司） 的关联（连）（简称关联）交易行为，保护公司、股东、特 别是中小股东和债权人的合法权益，保证公司关联交易决策 行为的公允性，根据《中华人民共和国证券法》《上海证券 交易所股票上市规则》和《香港联合交易所有限公司证券上 市规则》（简称两地上市规则）、《上海证券交易所上市公 司自律监管指引第 1 号——规范运作》（上证发〔2023〕193 号）、《上海证券交易所上市公司自律监管指引第 5 号—— 交易与关联交易》（上证发〔2023〕6 号）等法律、法规和 规范性文件以及《中国交通建设股份有限公司章程》的相关 规定，制定本办法。 第二条 公司在上海证券交易所和香港联合交易所有限 公司（分别简称为上交所和联交所）两地上市，关联交易管 理应当同时遵守两地 ...

老百姓大药房连锁股份有限公司 股票代码：603883 二〇二五年六月 目 录 担保的议案 议案 老百姓大药房连锁股份有限公司 股东大会会议须知 一、会议按照法律、法规、有关规定和《公司章程》的规定进行，请参会人 员自觉维护会议秩序，防止不当行为影响其他股东合法权益。 二、为能及时、准确地统计出席会议的股东（股东代理人）所代表的持股总 数，登记确认出席股东大会的各位股东或其代理人参会资格，各位股东及股东代 理人在股东大会参会登记日（2025 年 6 月 26 日-27 日）须先通过信函、电子邮 件方式登记。 三、参会股东及股东代理人须携带身份证明文件（身份证、营业执照等）及 相关授权文件办理现场会议登记手续及有关事宜。未能提供有效证明文件并办理 登记的，不得参加现场表决和发言。除出席本次会议的公司股东、董事、监事、 高级管理人员、公司聘请的见证律师、相关工作人员以及董事会邀请的人员外， 公司有权依法拒绝其他人员进入会场。 四、本次大会谢绝股东及股东代理人个人录音、拍照及录像，对扰乱会议的 正常秩序和会议议程、侵犯公司和其他股东及股东代理人的合法权益的行为，会 议工作人员有权予以制止，并及时报有关部门处理。 五、 ...

Core Viewpoint - The Shanghai Film Co., Ltd. is preparing for its 2024 annual profit distribution plan and the mid-term cash dividend for 2025, emphasizing the importance of maintaining shareholder rights and ensuring orderly conduct during the upcoming shareholder meeting [1][2][5]. Meeting Procedures - The shareholder meeting will be held on June 26, 2025, at 14:00, with provisions for both on-site and online voting [5]. - Only authorized personnel, including shareholders, directors, and invited guests, will be allowed to attend the meeting, ensuring the meeting's seriousness and order [1][2]. - Shareholders wishing to speak must register in advance and adhere to time limits for their remarks [2][3]. Agenda Items - The agenda includes the presentation of the 2024 Board of Directors' report, the Supervisory Board's report, and the financial statements for 2024 [5][6][7]. - A proposal for the 2024 profit distribution plan is included, which states that no profit distribution will occur, and no capital reserve will be converted into share capital [8][10]. - The company plans to propose a mid-term cash dividend for 2025, with an expected amount not less than 40% of the corresponding period's net profit attributable to shareholders [10][11]. Financial Highlights - The company's undistributed profits at the end of the reporting period amount to approximately RMB 458.21 million [8]. - The total cash dividend for the previous year was RMB 43.03 million, down from RMB 51.09 million the year before [8][9]. Audit and Compliance - The company has proposed to reappoint Lixin Certified Public Accountants as the auditing firm for the 2025 fiscal year, highlighting their long-standing reputation and compliance with regulatory standards [11][12][15]. - The audit fees for 2024 are reported to be RMB 1.8 million, with the specific amount for 2025 to be determined by mutual agreement [12][14]. Related Transactions - The company has outlined expected related party transactions for 2024, with significant amounts anticipated for ticket revenue sharing and service procurement [17][18]. - The total expected related party transactions for 2025 are projected to exceed those of 2024, reflecting anticipated growth in the industry [18][19].

Core Viewpoint - The company intends to transfer its 10.0581% stake in Shandong Luxin Huijin Holdings Co., Ltd. for 203.0274 million yuan to Shandong Investment Co., Ltd. to focus on its main business and reduce related party transactions [3][5][7]. Group 1: Share Transfer Details - The transfer price for the 10.0581% stake in Luxin Huijin is set at 203.0274 million yuan, with the profits and losses from the assessment date to the transfer date to be enjoyed by Shandong Investment [3][6]. - The transaction has been approved by the company's board and requires shareholder approval, with related shareholders abstaining from voting [3][5]. - The company has conducted over 30 million yuan in related party transactions with the same related party in the past 12 months, exceeding 5% of the latest audited net assets [3][5]. Group 2: Financial Information of Related Parties - As of December 31, 2024, Shandong Investment had total assets of 7.42 billion yuan and net assets of 2.982 billion yuan, with an operating income of 323 million yuan and a net profit of 104 million yuan for the year [5][9]. - Luxin Huijin had total assets of 6.596 billion yuan and net assets of 2.183 billion yuan, with an operating income of 323 million yuan and a net profit of 135 million yuan for the same period [5][9]. Group 3: Impact of the Transaction - The completion of this transaction is expected to result in an investment gain of approximately 24.007 million yuan for the company, subject to confirmation by the annual audit [7][19]. - The transaction aligns with the company's long-term strategy to reduce non-performing assets and does not harm the interests of the company or minority investors [19]. Group 4: Related Party Transactions - The company’s wholly-owned subsidiary, Shandong High-tech Venture Capital Co., Ltd., plans to transfer its rights to the income and voting rights of its 9.79% stake in Shandong Longli Biological Technology Co., Ltd. to Shandong Financial Asset Management Co., Ltd. [8][19]. - The transfer price for the income rights is set at 4.3962 million yuan, with the voting rights being entrusted to the receiving party [19]. Group 5: Board Elections - The company is preparing for the election of a new board of directors as the current term is nearing completion, with nominations for non-independent and independent directors being proposed [21][25]. - The proposed candidates for the non-independent director positions include individuals with extensive experience in finance and management [21][25].

Group 1 - The company announced an increase in temporary proposals for the second extraordinary shareholders' meeting scheduled for June 27, 2025 [2][5] - Shanghai Zhongneng Enterprise Development (Group) Co., Ltd., holding 29.20% of the shares, submitted a temporary proposal on June 15, 2025 [2] - The board of directors approved the addition of a non-independent director to the board during the 41st meeting [2][3] Group 2 - The voting for the shareholders' meeting will take place through the Shanghai Stock Exchange network voting system on the day of the meeting [3] - The original equity registration date for the shareholders' meeting remains unchanged, set for June 23, 2025 [4] - The meeting will be held at the company's conference room at 14:30 on June 27, 2025 [5] Group 3 - The proposals to be voted on include amendments to the "Related Party Transaction Management Measures" and "Implementation Management Measures for Senior Management Annual Salary System" [8] - A proposal for the implementation of a technical transformation project with an annual production capacity of 119,000 tons of bio-fermentation products is also included [8] - There are no related shareholders that need to abstain from voting [6]

Core Viewpoint - Angang Steel Co., Ltd. plans to engage in a financing lease transaction with Shanghai Dingyi Leasing Co., Ltd. for an amount not exceeding 100 million yuan, with a lease term of 3-5 years, to support its operational needs [1][2]. Summary by Sections 1. Overview of Related Transactions - The company intends to lease equipment related to blast furnace processes and dust control systems through a sale-leaseback arrangement with Shanghai Dingyi, with the financing amount capped at 100 million yuan [1][2]. - This transaction is classified as a related party transaction and does not constitute a major asset restructuring [1][2]. 2. Purpose and Reason for the Transaction - The financing lease is aimed at meeting the company's business development needs [2]. 3. Board Voting Situation - The proposal for the financing lease was approved at the company's sixth temporary board meeting in 2025, with related directors abstaining from the vote [2]. 4. Related Party Introduction - Angang Steel Group Co., Ltd. holds 67.65% of the company's shares, making it the controlling shareholder, and is connected to Shanghai Dingyi through its subsidiary [2]. - Shanghai Dingyi Leasing Co., Ltd. has a registered capital of 170 million yuan and operates in the financing leasing sector [4]. 5. Pricing Policy and Basis - The pricing for the transaction is based on market rates and is deemed fair, ensuring no harm to the company's interests [4]. 6. Impact of the Related Transaction on the Company - The transaction is expected to support the company's operational needs without affecting its independence or normal business operations [5]. 7. Required Approval Procedures - The transaction requires approval from the company's shareholders' meeting [2][5]. 8. Historical Related Transactions - In the past 12 months, the company has engaged in related transactions with Shanghai Dingyi amounting to 137 million yuan, excluding the current transaction [7].

证券代码：688210 证券简称：统联精密 公告编号：2025-031 深圳市泛海统联精密制造股份有限公司关于 子公司以知识产权质押等方式向金融机构申请授信的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本次交易概述 深圳市泛海统联精密制造股份有限公司（以下简称"公司"）子公司深圳市 泛海统联精密模具有限公司（以下简称"精密模具"）、深圳市泛海统联智能制造 有限公司（以下简称"智能制造"）为拓宽融资渠道，同时降低融资成本，拟向 深圳市高新投小额贷款有限公司（以下简称"高新投小额贷款"）申请融资授信 额度。其中，精密模具以其名下有权处分的一项专利作为质押担保，向高新投小 额贷款申请 2,000.00 万元融资授信额度；智能制造拟向高新投小额贷款申请 投融资担保"）为公司子公司申请上述总计不超过人民币 3,500 万元的授信额度 提供连带责任保证担保，公司控股股东、实际控制人杨虎先生及其配偶王小林女 士对高新投融资担保为公司子公司上述融资提供的担保进行反担保，具体以最终 签署的保证合同为准。上述融资授信额度均用于公 ...